HIV :: HIV therapy drugs reach one in five-study

Only one in five people with HIV in poor and middle-income countries receives the drugs that treat the virus, said a report by the U.S. Centers for Disease Control and Prevention on Thursday.

HIV :: New Generic AIDS Drug for AIDS Relief

The Food and Drug Administration (FDA) today announced the tentative approval of generic abacavir (a-BAK-a-veer) sulfate tablets manufactured by Aurobindo Pharma LTD. of Hyderabad, India. Abacavir sulfate tablets are the first generic version of the already approved Ziagen Tablets, an anti-HIV medication manufactured by GlaxoSmithKline. This product will now be available for consideration for purchase under the President’s Emergency Plan for AIDS Relief.

Stress :: How to reduce STRESS?

We live in times when stress has become part of our physical existence. Stress oriented problems like hypertension, heart disease, diabetes, various kinds of ulcers and even spondylosis are increasing by the day. Stress is normally different from what we consider as disease: for it has no biological structure as in the case germs and virus. It cannot be cultivated or observed under a microscope. Rightly so modern drugs and methods have failed in producing a cure for health problems related to stress. At the most it has been able to provide temporary relief from some symptoms.

Influenza :: Bird Flu scare

Influenza experts have urged nations not to lower their guard against the deadly H5N1 virus, saying it now survives longer in higher summer temperatures.

Kaposi’s Sarcoma :: Discovery of a Kaposi’s Sarcoma Associated Herpesvirus

Researchers at the National Institute of Allergy and Infectious Disease (NIAID), a component of the National Institutes of Health (NIH), have identified a critical human cell surface molecule involved in infection by Kaposi’s sarcoma herpesvirus (KSHV), the virus that causes Kaposi’s sarcoma and certain forms of lymphoma. Kaposi’s sarcoma is a major cancer associated with HIV/AIDS, and it typically manifests as multiple purple-hued skin lesions.

Cervical Cancer :: Cervical cancer vaccine gives long protection

A vaccine that protects women against a virus that causes cervical cancer is effective for more than four years, researchers said. They found that women given GlaxoSmithKline Plc’s cervical cancer vaccine Cervarix had high levels of antibodies against two of types of the human papillomavirus (HPV) for up to 4.5 years after receiving their last dose.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack